InvestorsHub Logo
Followers 0
Posts 3727
Boards Moderated 0
Alias Born 10/23/2017

Re: None

Monday, 08/27/2018 2:45:59 PM

Monday, August 27, 2018 2:45:59 PM

Post# of 695657
Even the Bosch presentation is "blinded." each of the other speakers at this presentation dinner has a write-up on what they will discuss and what their company does.

Bosch, Nothing: 8:35 Clinical Development of Dendritic Cell-Based Immunotherapies for Cancer. Marnix Bosch, PhD, Chief Technical Officer, Northwest Biotherapeutics
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News